Test Price
1,800 AED✅ Home Collection Available
Chronic Leukemia Panel in UAE | 1800 AED | DHA Licensed Laboratory
Executive Summary & Core Metrics
The gold-standard flow cytometry panel, fully mapped to DHA & ISO 9001:2015 requirements, for confident chronic leukemia detection and genetic profiling.
- ✓ 99.9% Diagnostic Sensitivity – ISO 15189 & ISO 9001:2015 accredited processing delivers clinical-grade accuracy.
- ✓ Hospital Extraction Only – Sample collection is conducted strictly within an accredited hospital facility; mobile home phlebotomy is disabled for safety.
- ✓ Post-Test Clinical Guidance – Complimentary telephonic result interpretation by a DHA-licensed specialist.
- ✓ Direct Insurance Verification – WhatsApp +971 54 548 8731 for instant pre-approval & billing.
Compliant with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields.
Test Overview & Methodology
The Chronic Leukemia Panel is a high‑sensitivity multiparameter flow cytometry (MFC) analysis, optionally reflexed to next‑generation sequencing (NGS), that detects leukemia‑associated immunophenotypes and clinically actionable genetic aberrations (BCR‑ABL1, TP53, IGHV). Designed for haematologists, medical oncologists, and genetic counsellors managing patients with suspected or confirmed chronic leukaemia.
| Feature | Our Chronic Leukemia Panel | Closest Alternative (Standard FC Panel) |
|---|---|---|
| Precision | MFC + NGS reflex, LC‑MS/MS validated reagents – 99.9% sensitivity | Conventional 4‑color FC without molecular reflex |
| Method | Multiparameter flow cytometry (≥10 markers) + BCR‑ABL1, TP53, IGHV NGS | Basic 4‑6 color flow cytometry, no genetic sequencing included |
| Speed | Results within 1–2 working days | Often 3–5 days for standard panels, with separate genetic testing |
| Regulatory | DHA, ISO 15189, LOINC 96669‑7, ICD‑10 coded | May lack full UAE‑specific compliance and accreditation |
Physician Insight & Safety Protocols
Note from Mr. Prabhakar Reddy Kalathoor (Specialist Diagnostic Radiology, DHA License: 61713011):
“Every Chronic Leukemia Panel result must be interpreted in the full clinical context. A positive finding does not equate to an immediate cancer diagnosis; it flags the need for further haematological evaluation and possible bone marrow biopsy. My team is here to support your journey with compassionate, evidence‑based guidance—never make changes to your care plan based on a single test without consulting your specialist.”
⚠ Medication Warning
Do not discontinue prescribed medication (e.g., imatinib, ibrutinib) without consulting your doctor. Abrupt cessation can provoke disease flare or tumour lysis syndrome. Always discuss any result with your treating haematologist/oncologist.
🛑 Safety Exclusion Criteria & ER Red Flags
- Exclusion Criteria: Active systemic infection (fever >38°C), recent chemotherapy (within 2 weeks), or pregnancy (requires specialist clearance). Test not intended for emergency diagnosis.
- Emergency Red Flags: If you experience sudden severe bruising, uncontrolled bleeding, persistent fever >38°C, drenching night sweats, or unexplained weight loss >5% in a month, seek immediate ER care. Do not wait for test results.
Patient FAQ & Clinical Guidance
1. What exactly does the Chronic Leukemia Panel detect, and who should order it?
The Chronic Leukemia Panel is a high-precision flow cytometry that detects leukemia-associated immunophenotypes and genetic markers within 1–2 days. It is clinically indicated for patients with abnormal complete blood counts (CBC), unexplained splenomegaly, or constitutional symptoms suggestive of a chronic myeloproliferative or lymphoproliferative disorder. Haematologists, oncologists, and genetic counsellors order this panel to confirm diagnosis, classify the leukaemia subtype (e.g., CML, CLL), and guide targeted therapy such as tyrosine kinase inhibitors or BCL‑2 antagonists.
2. How is the sample collected and what should I expect?
A DHA-licensed healthcare professional collects either a peripheral blood sample or a bone marrow aspirate under sterile conditions at an accredited hospital facility. For peripheral blood, it is similar to a routine blood draw. For bone marrow, local anaesthesia is applied to minimize discomfort. You must provide a doctor’s prescription and avoid anticoagulants as advised. Home collection is not available for this test due to the invasive nature of bone marrow aspiration.
3. When will I receive my results and how should I act on them?
Your comprehensive report, including immunophenotypic profile and NGS‑mutation analysis, is delivered securely within 1–2 business days of sample receipt. A DHA‑licensed specialist will offer a free telephonic consultation to explain the findings and highlight any actionable genetic variants (e.g., BCR‑ABL1 p210 transcript). Do not self-interpret; always follow up with your treating physician who will integrate the results with imaging and clinical staging to recommend the next step, such as a confirmatory bone marrow biopsy or initiation of molecularly targeted therapy.
UAE Regulatory & Data Privacy Adherence
This diagnostic service complies with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical testing safety and patient consent follow Federal Decree-Law No. 4 of 2016 on Medical Liability. All laboratory procedures are ISO 15189 accredited and adhere to DHA standards for quality and confidentiality.
Clinical & Logistical Metadata
| Test Name | Chronic Leukemia Panel |
| Price (AED) | 1,800 AED |
| Turnaround Time | 1–2 business days |
| Sample Type / Matrix | Peripheral blood or bone marrow aspirate (Hospital extraction only – mobile home phlebotomy is disabled for safety) |
| Methodology Used | Multiparameter flow cytometry (MFC) + NGS reflex (BCR-ABL1, TP53, IGHV) |
| ICD-10-CM Code | C95.1 (Chronic leukemia of unspecified cell type) |
| LOINC Code | 96669-7 |
| DHA Facility License & Laboratory Address | DHA License No. 1143 · Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE · DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians